"objectively slow markers of neurodegeneration...." quote from that SCIENCE TIMES article. It's a "news" article - , it sources from Anavex Press releases...nobody takes it as a "peer reviewed" article. It is pro-active PR effort by AVXL IR.
that quotes refers to a FACT, people.
The fact that this neuro researcher is excited about our drug IS worth printing and putting out to the public.
People here bitch about IR doing nothing -
this is IR in action....publicizing A2-73's VERY POSITIVE BIOMARKER effect in AD. !!